SCHEMBL2615052

SCHEMBL2615052

CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@H]5CO[C@](Cn6cncn6)(c6ccc(F)cc6Cl)O5)cc4)CC3)cc2)c1=O

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 19/20 0.88
ABCG2 Q9UNQ0 4/20 0.88
LMNA P02545 3/20 0.88
CYP51A1 Q16850 3/20 0.88
ABCB11 O95342 3/20 0.88
CYP8B1 Q9UNU6 3/20 0.88
FYN P06241 2/20 0.88
MEN1 O00255 2/20 0.88
ABCB1 P08183 2/20 0.88
MAPT P10636 2/20 0.88
MAPK1 P28482 2/20 0.88
KMT2A Q03164 2/20 0.88
HIF1A Q16665 2/20 0.88
CXCR1 P25024 1/20 0.88
TACR1 P25103 1/20 0.88
AVPR2 P30518 1/20 0.88
CCR4 P51679 1/20 0.88
PDE4D Q08499 1/20 0.88
NR1I2 O75469 2/20 0.65
HSP90AA1 P07900 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Itraconazole SCHEMBL8849763 0.95 CYP3A4 (0.90) CYP3A4ABCG2LMNACYP51A1ABCB11
Itraconzole SCHEMBL1650334 0.94 CYP3A4 (0.79) CYP3A4ABCG2LMNACYP51A1ABCB11
Itraconzole SCHEMBL2615053 0.94 CYP3A4 (0.79) CYP3A4ABCG2LMNACYP51A1ABCB11
Itraconazole SCHEMBL14875903 0.94 CYP3A4 (1.00) CYP3A4ABCG2LMNACYP51A1ABCB11
Itraconazole SCHEMBL20464865 0.94 CYP3A4 (1.00) CYP3A4ABCG2LMNACYP51A1ABCB11
Itraconazole SCHEMBL64913 0.94 CYP3A4 (1.00) CYP3A4ABCG2LMNACYP51A1ABCB11
Itraconazole SCHEMBL15948108 0.94 CYP3A4 (1.00) CYP3A4ABCG2LMNACYP51A1ABCB11
Itraconazole SCHEMBL14875705 0.94 CYP3A4 (1.00) CYP3A4ABCG2LMNACYP51A1ABCB11
Itraconzole SCHEMBL12887924 0.94 CYP3A4 (0.79) CYP3A4ABCG2LMNACYP51A1ABCB11
Itraconzole SCHEMBL4149722 0.94 CYP3A4 (0.79) CYP3A4ABCG2LMNACYP51A1ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120095217-A1 FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2012-04-19 US disclosed
US-20120095217-A1 FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2012-04-19 US disclosed
WO-2010081036-A2 FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2010-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095217-A1 FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF FLI1, CDC73, FOS CYP3A4 1063/4885ABCG2 230/4885LMNA 1375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.